Aldehyde Dehydrogenase‐2 Alleviates Septic Myocardial Injury by Inhibiting Caspase‐11‐Mediated Noncanonical Pyroptosis
Cardiovascular Therapeutics · 2026
DOI: 10.1155/cdr/5289405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2026. Verfasst von Huan Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical University, Bengbu, Anhui, China, bbmc.edu.cn. Hauptthemen laut MEDLINE: Aldehyde Dehydrogenase, Mitochondrial, Pyroptosis, Sepsis, Myocytes, Cardiac. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bengbu Medical College.
Abstract (Originalsprache)
Purpose
The purpose of this study is to investigate the role of aldehyde dehydrogenase‐2 (ALDH2) in septic myocardial injury, focusing on noncanonical pyroptosis.
Methods
In vivo, C57BL/6J mice were divided into five groups: Sham, cecal ligation and puncture (CLP), CLP + Alda‐1 (ALDH2 agonist), Sham + dimethyl sulfoxide (DMSO, solvent control), and CLP + DMSO. Cardiac function and histological/ultrastructural changes were assessed via echocardiography, hematoxylin–eosin (HE) staining, and transmission electron microscopy (TEM). Tumor necrosis factor‐ α (TNF‐ α ) and noncanonical pyroptosis‐related proteins (caspase‐11, gasdermin‐D [GSDMD], high mobility group box 1 [HMGB1], and receptor for advanced glycation end products [RAGE]) were measured by enzyme‐linked immunosorbent assay (ELISA) and western blotting. Coimmunoprecipitation (CO‐IP) explored molecular mechanisms. In vitro, H9C2 cells were divided into six groups: Control, lipopolysaccharide (LPS)‐treated, ALDH2‐green fluorescent protein (GFP), LPS + ALDH2‐GFP, GFP, and GFP + LPS. Cell viability, lactate dehydrogenase (LDH) release, creatine kinase isoenzymes (CK‐MB), and target protein levels were detected via spectrophotometry, western blotting, and immunofluorescence (IF).
Results
In vivo, Alda‐1 significantly attenuated CLP‐induced cardiac dysfunction and reduced myocardial histological damage and ultrastructural impairment. In vitro, ALDH2 overexpression lowered LPS‐induced H9C2 cell viability, CK‐MB, and LDH release. Upregulating ALDH2 significantly reduced caspase‐11, HMGB1, and RAGE expression. CO‐IP showed ALDH2 interacted with HMGB1, RAGE, and GSDMD.
Conclusion
ALDH2 protects the myocardium from septic injury by inhibiting caspase‐11‐mediated noncanonical pyroptosis, possibly via direct interactions with GSDMD, HMGB1, and RAGE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical University, Bengbu, Anhui, China, bbmc.edu.cn.
- Department of Graduate Management, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University, Bengbu, Anhui, China, bbmc.edu.cn.
- Department of Physiology, Bengbu Medical University, Bengbu, Anhui, China, bbmc.edu.cn.
- Department of Anatomy, Bengbu Medical University, Bengbu, Anhui, China, bbmc.edu.cn.
ORCID-Profile: Huan Liang, Hongwei Ye, JiaHui Wang, Qin Gao
Förderung
- Bengbu Medical College
Zitieren
APA
Liang, H., He, Y., Wang, Y., Zhang, R., Yu, M., Ye, H., Wang, J., & Gao, Q. (2026). Aldehyde Dehydrogenase‐2 Alleviates Septic Myocardial Injury by Inhibiting Caspase‐11‐Mediated Noncanonical Pyroptosis. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/5289405
Vancouver
Liang H, He Y, Wang Y, Zhang R, Yu M, Ye H, et al. Aldehyde Dehydrogenase‐2 Alleviates Septic Myocardial Injury by Inhibiting Caspase‐11‐Mediated Noncanonical Pyroptosis. Cardiovascular Therapeutics. 2026. doi:10.1155/cdr/5289405
BibTeX
@article{Liang2026,
author = {Liang, Huan and He, Yuying and Wang, Yiren and Zhang, Rui and Yu, Mengjie and Ye, Hongwei and Wang, JiaHui and Gao, Qin},
title = {Aldehyde Dehydrogenase‐2 Alleviates Septic Myocardial Injury by Inhibiting Caspase‐11‐Mediated Noncanonical Pyroptosis},
journal = {Cardiovascular Therapeutics},
year = {2026},
doi = {10.1155/cdr/5289405}
}
EUVIMED